<DOC>
	<DOCNO>NCT01960634</DOCNO>
	<brief_summary>This multi-centric translational study biological sample collection . The aim study validate method detect BRAFV600 blood sample . Samples : Blood patient BRAFV600 metastatic melanoma collect follow standard medical practice . The treatment aim study . Patients treat either specific no-specific drug .</brief_summary>
	<brief_title>Translational Study BRAFV600 Serum Plasma Determination Patients With BRAFV600 Metastatic Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Confirmed diagnosis melanoma BRAFV600 Signed Informed Consent Form Unresectable phase III phase IV melanoma The patient start treatment melanoma ( either first line subsequent line )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>